MedTrace Logo

A Registry of Participants With Prostate Cancer in Asia

NCT02546908 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3644

Last updated 2020-09-22

No results posted yet for this study

Summary

The purpose of this study is to document prostate cancer (PC) management including diagnosis, prognosis, treatment, and care in real-world practice.

Conditions

  • Prostatic Neoplasms

Interventions

OTHER

No Intervention

This is an observational study. No study medication is provided will be provided as part of participation. Participants disease status, overall survival (OS), PFS, MFS, SRE-free survival, and time to castration (TTC) will be analyzed according to treatments prescribed while enrolled in the registry. All treatment decisions will be made at the discretion of the investigator or treating physician.

Sponsors & Collaborators

  • Janssen Research & Development, LLC

    lead INDUSTRY

Principal Investigators

  • Janssen Research & Development, LLC Clinical Trial · Janssen Research & Development, LLC

Eligibility

Min Age
21 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-09
Primary Completion
2020-09-01
Completion
2020-09-01

Countries

  • China
  • India
  • Japan
  • Malaysia
  • Singapore
  • South Korea
  • Taiwan
  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02546908 on ClinicalTrials.gov